Urgent Management of Adult Combined Immunodeficiency Presenting with Diarrhea

Immediate Recognition and Stabilization

Recognize that adult patients with combined immunodeficiency and acute diarrhea constitute a medical emergency; early intervention markedly improves survival compared with delayed care. 1
Initiate aggressive fluid resuscitation: use reduced‑osmolarity oral rehydration solution for mild‑to‑moderate dehydration and isotonic intravenous crystalloids (lactated Ringer’s or normal saline) for severe dehydration, shock, or altered mental status. 2

Begin broad‑spectrum antimicrobial therapy immediately in immunocompromised adults with severe illness and diarrhea to reduce mortality from invasive infection. 2
Use a third‑generation cephalosporin (e.g., ceftriaxone) when bacterial sepsis is suspected, providing coverage for common gram‑negative pathogens. 3
Add azithromycin if clinical features suggest bacillary dysentery (e.g., frequent scant bloody stools, fever, abdominal cramps). 3
Avoid antibiotics if Shiga‑toxin‑producing E. coli (STEC) infection is suspected or confirmed, because therapy increases the risk of hemolytic‑uremic syndrome. 3
De‑escalate or discontinue antimicrobial agents promptly once a specific pathogen is identified, particularly to prevent prolonged carrier states with non‑typhoidal Salmonella and to support antimicrobial stewardship. 2

Initiate intravenous immunoglobulin (IVIG) replacement as the foundational treatment for combined immunodeficiency; IVIG reduces infection frequency and supports overall immune function. 1

Refer the patient without delay for hematopoietic stem cell transplantation (HSCT), the definitive curative option; early referral before the onset of severe infection is the strongest predictor of favorable long‑term outcomes. 1
Consider gene‑therapy approaches in selected individuals when a specific molecular defect has been identified and targeted therapy is available. 1

Perform a comprehensive immune assessment, including quantitative serum immunoglobulins (IgG, IgM, IgA), complete blood count with differential, and lymphocyte subset analysis (CD4⁺, CD8⁺, B‑cell, NK‑cell panels). 1
Anticipate laboratory patterns such as pan‑hypogammaglobulinemia, lymphopenia or alymphocytosis, and absent cellular immune responses on in‑vitro stimulation assays; the exact phenotype varies with the underlying genetic defect. 1
Obtain molecular genetic testing to confirm the diagnosis, enable precise genetic counseling, and identify eligibility for gene‑specific therapies. 1

Resume an age‑appropriate diet promptly after rehydration to support nutritional recovery. 2
Offer probiotic supplementation (e.g., Lactobacillus GG or Saccharomyces boulardii) to shorten diarrheal duration, lessen symptom severity, and favorably modulate gut microbiota and intestinal immune responses. 2

Do not use antimotility agents such as loperamide in patients with suspected inflammatory diarrhea or fever, as they may exacerbate disease and precipitate toxic megacolon. 2

Recognize that chronic diarrhea, failure to thrive, and recurrent infections may be the first manifestation of previously undiagnosed combined immunodeficiency in adults; a high index of suspicion facilitates timely diagnosis and treatment. 1

The villus‑to‑crypt (V:C) ratio is ≥ 3 : 1 in correctly oriented duodenal biopsies; ratios < 3 : 1 denote partial villous atrophy and ratios approaching 0 indicate total atrophy【@1】.
A V:C ratio < 3 : 1 in an adult with combined immunodeficiency and chronic diarrhea signals villous atrophy and mandates urgent evaluation for opportunistic infections, immunoglobulin replacement, and referral for hematopoietic stem cell transplantation【@1】.

Proper tissue orientation by an experienced laboratory technician is essential; misoriented biopsies cannot be reliably evaluated for V:C ratio【@1】.
Obtain 4–6 properly oriented duodenal biopsies, including specimens from both the duodenal bulb and the second portion of the duodenum, to maximize pathogen detection and reduce sampling error【@9】.

Histologic Feature	Reporting Requirement	Reference
Number & orientation of biopsies (including duodenal bulb)	Must be documented	【@7】
Architectural classification (normal, partial, subtotal, total villous atrophy)	Must be documented	【@2】
Villus height‑to‑crypt depth ratio	Normal ≥ 3 : 1; report actual ratio	【@3】
Lamina propria cellularity – presence/absence of plasma cells	Absence strongly suggests common variable immunodeficiency (CVID)	【@8】
Crypt hyperplasia	Presence should be noted	【@8】
Intra‑epithelial lymphocyte (IEL) count	Normal < 25 IELs per 100 enterocytes; report count	【@1】
Granulomas / goblet cell density	Granulomas suggest Crohn’s disease; reduced goblet cells suggest autoimmune enteropathy	【@9】

Absence of plasma cells in the lamina propria together with villous atrophy is a strong histologic marker for CVID【@8】.
Negative celiac serology does not exclude villous atrophy caused by other mechanisms in combined immunodeficiency patients【@1】.

Improperly oriented biopsies may yield false‑negative V:C assessments; always verify orientation before interpretation【@1】.
Review of biopsy orientation and alternative diagnoses should be performed by an experienced gastrointestinal pathologist【@9】.
Increased IELs (≥ 25/100 enterocytes) without villous atrophy should not be classified as seronegative enteropathy; villous atrophy is a required criterion【@9】.

All statements are supported by peer‑reviewed citations as indicated.